ѻý

Cancer and COVID; Booze and Cancer; 'Screech' Starts Chemo

<ѻý class="mpt-content-deck">— News, features, and commentary about cancer-related issues
MedpageToday
Cancer cells with OncoBreak in the center.

Patients in cancer remission had a high risk of developing ; however, patients who received in-person cancer care at a facility with aggressive prevention efforts had a low risk of acquiring the infection. (Penn Medicine)

Merck KGaA of Germany ended a phase III trial of the bifunctional immunotherapy drug bintrafusp alfa in non-small cell lung cancer after an independent advisory committee concluded the study of progression-free survival.

Regular aspirin use in bladder and breast cancers. (newsGP, JAMA Network Open)

A simplified DNA screening test accurately identified specific alterations in associated with colon, endometrial, and other cancers. (Journal of Molecular Diagnostics)

An upcoming cardio-oncology program will include the latest information about diagnosis and management of in cancer survivors. (American College of Cardiology)

Immuno-oncology will continue to be a of the biopharmaceutical industry during 2021. (GlobalData)

More have a certain type of genetic mutation than expected, making more patients eligible for a treatment that targets the mutation. (Children's Hospital of Philadelphia)

AstraZeneca announced that the FDA of fam-trastuzumab deruxtecan-nxki (Enhertu) to include locally advanced or metastatic HER2-positive gastric or gastroesophageal junction cancer.

More evidence about the cancer burden associated with . (Cancer Epidemiology)

Oncologists get more help in will have severe chemotherapy-associated side effects. (City of Hope, Journal of Clinical Oncology)

Japanese researchers discovered a potentially important link between . (Tokyo Medical and Dental University)

Dustin Diamond, better known as from the popular TV series "Saved by the Bell," received his first round of chemotherapy for stage IV small-cell carcinoma, according to his publicist. (Fox News)

  • author['full_name']

    Charles Bankhead is senior editor for oncology and also covers urology, dermatology, and ophthalmology. He joined ѻý in 2007.